Many people might be scratching their heads about what the Elmiron lawsuit is all about. In short, the lawsuit is about a medicine called Elmiron (pentosan polysulfate sodium) which is used to treat a condition called interstitial cystitis (IC). The lawsuit claims that the manufacturer of Elmiron, Janssen Pharmaceuticals, failed to warn patients and doctors about the serious risks associated with taking the drug. If you want to learn more about the effects of Elmiron and stay updated, read this informative article about the Elmiron lawsuit and look below for more information.
What is Elmiron?
Elmiron is the only FDA-approved treatment for IC, and as such, many patients have turned to it in order to find relief from their symptoms. However, the lawsuit claims that Janssen knew or should have known about the potential risks associated with Elmiron use, but failed to disclose it to the patients who depended on it for relief.
You see, IC is a debilitating condition, characterized by pelvic pain, urinary frequency and urgency, and often, problems with sexual function. It can have a profound effect on every aspect of a patient’s life, including their relationships, mental health, and ability to work. Because there are no cures for IC, patients have to rely on treatments like Elmiron to help manage their symptoms.
What are the risks associated with Elmiron?
The lawsuit claims that Janssen knew or should have known about the potential risks associated with Elmiron use, but failed to disclose it to the patients who depended on it for relief. These risks include the following.
Risk of Pigmentary Maculopathy
One of the most serious risks associated with Elmiron is pigmentary maculopathy, a condition that can lead to blindness. The lawsuit claims that Janssen knew or should have known about this risk, but failed to warn patients or doctors about it. While previous labels stated that Elmiron could lead to certain vision issues, it never stated that the vision loss and damage was permanent.
Risk of Other Eye Problems
In addition to pigmentary maculopathy, other diseases associated with Elmiron also include:
- Cystoid macular edema: This is the accumulation of fluid in the macula, which is the part of the eye responsible for central vision.
- Macular neovascularization: This is the formation of new blood vessels in the macula.
- Retinal pigmentary changes: This is a change in the way that light is absorbed by the retina, which can lead to vision problems.
- Retinal pigment epithelium (RPE) atrophy: This is a condition in which the cells that make up the retina begin to break down, which can lead to vision loss.
While these risks are serious, it’s important to note that not everyone who takes Elmiron will experience them. However, if you have taken Elmiron and are experiencing any of these symptoms, it’s important to see an eye doctor right away.
What Should I Do If I’ve Been Affected By Elmiron?
If you or someone you love has taken Elmiron and has experienced any of the above-mentioned symptoms, you may be entitled to compensation. The first step is to speak with a lawyer who specializes in Elmiron lawsuits to discuss your legal options. As of January 2022, an MDL has been established in New Jersey, and cases are currently being consolidated there. If you’re considering filing a lawsuit, it’s important to do so as soon as possible, as there may be deadlines that apply to your case.
